Here’s the reaction of Clarita Carlos to the life-threatening condition of Kris Aquino
CLARITA CARLOS – The retired Political Science took to social media wherein she asked for prayers over the life-threatening illness of Kris Aquino.
It was just recently when the Queen of All Media revealed that her illness is life-threatening.
In an Instagram post, Kris shared that by the end of April, they have learned that her illness has become “life-threatening.” She revealed that she has three confirmed autoimmune diseases.
First is chronic spontaneous urticarial which can make a person feel itchy and uncomfortable, and it causes hives that come and go unexpectedly. The second one is autoimmune thyroiditis which is the inflammation of the thyroid and sometimes it happens because your body makes antibodies that attack your thyroid by mistake, Web MD stated.
After her third skin biopsy, pathologists in the Philippines and in the US concluded that Kris has vasculitis. “To be very specific – late stage 3 of Churg Strauss Syndrome now also known as EGPA,” she said.
Kris also shared that she needs to go to the US because the medicine that will help save her is not yet FDA-approved in the Philippines, as well as in Singapore.
Many were saddened by the revelation of Kris Aquino and among those is retired Political Science teacher Clarita Carlos.
In a Facebook post, she asked for prayers on the recovery of the actress-host from a life-threatening illness.
Here’s her FB post:
Meanwhile, Clarita Carlos is a retired professor of political science at the University of the Philippines.
She caught the media’s attention after being one of the panelists at SMNI’s presidential debate. At the time, she was praised and admired by netizens for her excellent and insightful opinions and questions of presidential contenders.
What can you say about this report? Share your thoughts or insights in the comment section below.
For more news and the latest updates, feel free to visit Newspapers.ph more often as well as our Facebook page and YouTube channel.